BioSpace News Archive

Direct Relief today announced it received a $5.1 million donation from Virgil Elings to complete funding for its new headquarters facility. The $40 million facility, which was dedicated today, includes both Direct Relief’s headquarters offices and the largest distribution hub for humanitarian medical aid in the United States.

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended December 30, 2018.

The nation’s opioid epidemic has claimed far too many lives in the United States.

apceth Biopharma GmbH, a leading contract manufacturing organization in the field of cell and gene therapy, announces today that Hitachi Chemical Co., Ltd. will enter into an agreement to acquire all shares of apceth Biopharma GmbH. This acquisition is expected to close in April 2019.

Invitrocue Limited (ASX: IVQ), a leading healthcare bio-analytic solutions provider, today released its Appendix 4C for the quarter ended 31 December 2018 (Reporting Period).

Sylentis, a PharmaMar Group company (MSE:PHM), has announced today the results of the HELIX [i]exploratory clinical trial; a Phase 3 efficacy and safety study with tivanisiran compared against artificial tears for the treatment of dry eye disease

Expanding at a rather modest annual growth rate of 4.6 percent, the global market for oxycodone is projected to reach a revenue of US$ 4 Billion in 2028—showcasing an absolute dollar opportunity of US$ 181.3 Mn, through 2018-2019.

The brain monitoring systems market is projected to expand at a healthy pace with global sales exceeding US$ 3.5 Bn by end of 2019, as per the latest research study by FMI.

“The drug you design ten years from now may already be obsolete,” Ivan Erill says. In a new study in Frontiers in Microbiology, Erill and colleagues describe how bacteria that existed hundreds of millions of years ago were already resistant to an antibacterial drug not invented until the 1930s

Cibus today announced the launch of its new seed brand, Falco™, offering North American canola growers four new canola varieties for the 2019 growing season, with additional varieties planned for next season.